People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...

Trade your diet soda for a tall glass of water, a new small-scale study argues. Women were more likely to drop pounds and see ...

CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

During a clinical trial, around 83% (10 out of 12) of patients who received a full dose of Zimislecel achieved complete ...

The American Diabetes Association, now endorses automated insulin delivery (AID) systems as the leading approach for ...

Adults with type 2 diabetes and chronic kidney disease have a lower risk for adverse renal outcomes with semaglutide, ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...